Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SHE:301584)
China flag China · Delayed Price · Currency is CNY
17.70
-0.47 (-2.59%)
At close: Nov 17, 2026

SHE:301584 Revenue

Shanghai C&D INNOSTIC Medical Technology Group had revenue of 4.52B CNY in the quarter ending March 31, 2026, with 1.96% growth. This brings the company's total for the last twelve months to 19.44B, up 7.64% year-over-year. In the year 2025, Shanghai C&D INNOSTIC Medical Technology Group had annual revenue of 19.43B with 8.41% growth. That makes Shanghai C&D INNOSTIC Medical Technology Group the 3,902nd largest company in the world by revenue and 498th in China.

Revenue (ttm)
19.44B
Revenue Growth
+7.64%
P/S Ratio
0.39
Revenue / Employee
9.19M
Employees
2,115
Market Cap
7.46B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Direct Selling Business 11.05B 56.9%
  • Distribution Business 8.05B 41.4%
  • Service Business 285.38M 1.5%
  • Unallocated Other 44.14M 0.2%

By Geography

Chart
  • East China 6.96B 35.8%
  • North China 3.51B 18.1%
  • Southwest China 2.42B 12.5%
  • Central China 2.07B 10.6%
  • Northeast China 1.60B 8.2%
  • Northwest China 1.50B 7.7%
  • South China 1.33B 6.9%
  • Unallocated 44.14M 0.2%
Fiscal year ended Dec 31, 2025 See the full SHE:301584 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202519.43B1.51B8.41%
Dec 31, 202417.92B2.48B16.06%
Dec 31, 202315.44B3.56B29.97%
Dec 31, 202211.88B1.86B18.54%
Dec 31, 202110.02B1.48B17.35%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.